Parenteral nutrition, or intravenous feeding, is a method of getting nutrition into your body through your veins. Depending on which vein is in use, this procedure is either total parenteral nutrition (TPN) or peripheral parenteral nutrition (PPN). It also can help people with conditions that result from low blood flow to their bowels.
High prevalence and rise in incidence rate of chronic diseases worldwide is a key factor driving the global parenteral nutrition market. Besides there are several factors that boost the global parenteral nutrition market.
The global parenteral nutrition market will grow by a rise in the number of cases of malnutrition and approvals of novel parenteral nutrition combinations worldwide. In terms of revenue, the global market was valued at US$ 5,299.5 Mn in 2017 and will grow with impressive CAGR in the forthcoming years.
What are the other prominent drivers of the global parenteral nutrition market?
The rise in cancer, AIDS, diabetes, Crohn’s disease, gastro-intestinal disorders, and short bowel syndrome cases has also fuelled the consumption of parenteral nutrition in recent years. Factors such as the increasing life expectancy due to advanced healthcare facilities coupled with innovation in the treatment of diseases it is mainly older people who are seeking for parenteral nutrition. Lot of time the patients with significant muscle mass loss medically known as sarcopenia due to under-nutrition.
People of all ages receive parenteral nutrition. It is given to infants and children, as well as to adults. If required then people can live well on parenteral nutrition. Many times, it is for a short period then decreased or discontinued when people switch to tube feeding or eat enough by mouth. Parenteral nutrition bypasses the normal digestion in the gastrointestinal tract. It is a sterile liquid chemical formula given directly into the bloodstream through an intravenous (IV) catheter (needle in the vein).
Perceive the Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3611
How diminished meal intake is rapidly growing the global parenteral nutrition market?
Every third person is hospitalized in the U.S. is at risk for malnutrition. Diminished meal intake also increases death risk, acc. to report published in the Journal of Parenteral and Enteral Nutrition. This malnutrition risk shows that hospital malnutrition remains a problem in U.S. hospital patients. In addition, the patients who have reduced intake have experience increased death risk. Moreover, they do not always receive optimal nutrition intervention. These results highlight the ongoing issues of poor oral intake and malnutrition risk in the hospital.
Parenteral nutrition is in clinical practice for over a quarter of a century. It provides better nutritional requirements for optimal growth and maturation of the person. It has revolutionized the management of chronic medical conditions. Advancement in techniques has led to the development of highly sophisticated delivery systems and catheters for parenteral nutrition. The global parenteral nutrition market is growing rapidly, with increasing incidence of malnutrition.
Which factors hinders the global parenteral nutrition market in larger run?
The rise of the global parenteral nutrition market is marred by the rising health risks incurred due to improper monitoring of health. After the uptake of parenteral nutrition, various cases of unexplained gaining of weight, allergic reactions, muscle pain, and shortness of breath have come to attention.
Furthermore, a study by The American Society for Nutrition states that consistent utilization of parenteral nutrition therapy may lead to metabolic complications and liver diseases.
Obtain the Report Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3611
Which regions will register promising growth in the coming years?
North America accounted for major revenue share and will continue to remains dominant region over the forecast period. Europe was the second largest market followed by the Asia Pacific. Asia Pacific market is projected to grow at the highest rate during the forecast period. The Middle East and Africa and Latin America are also expected to experience moderate growth in the parenteral nutrition market in the years to come.